非那雄胺，一种选择性5α-还原酶抑制剂，用于预防和治疗人类前列腺癌。 - Suppr

Suppr

超能文献

Finasteride, a selective 5-alpha-reductase inhibitor, in the prevention and treatment of human prostate cancer.

作者信息

Reddy G Kesava

出版信息

Clin Prostate Cancer. 2004 Mar;2(4):206-8. doi: 10.1016/s1540-0352(11)70045-2.

DOI:10.1016/s1540-0352(11)70045-2

PMID:15072601

Abstract

摘要

相似文献

Finasteride, a selective 5-alpha-reductase inhibitor, in the prevention and treatment of human prostate cancer.

Clin Prostate Cancer. 2004 Mar;2(4):206-8. doi: 10.1016/s1540-0352(11)70045-2.

Finasteride for prevention of prostate cancer.

Med Lett Drugs Ther. 2008 Jun 30;50(1289):49-50.

Guideline supports long-term use of medication to lower prostate cancer risk.

JAMA. 2009 May 6;301(17):1753-4. doi: 10.1001/jama.2009.560.

Prevention of prostate cancer with finasteride.

N Engl J Med. 2003 Oct 16;349(16):1569-72; author reply 1569-72.

Prostate cancer prevention with 5 alpha-reductase inhibitors.

Recent Results Cancer Res. 2011;188:109-14. doi: 10.1007/978-3-642-10858-7_9.

[The Prostate Cancer Prevention Trial (PCPT). Relevance for clinical practice].

Urologe A. 2007 Oct;46(10):1364, 1366-8, 1370. doi: 10.1007/s00120-007-1553-9.

Prostate cancer prevention trials in the USA.

Eur J Cancer. 2000 Jun;36(10):1312-5. doi: 10.1016/s0959-8049(00)00105-2.

High-grade prostate cancer and finasteride.

BJU Int. 2010 Feb;105(4):456-9. doi: 10.1111/j.1464-410X.2009.09089.x. Epub 2009 Nov 20.

The potential application of finasteride for chemoprevention of prostate cancer.

Ann N Y Acad Sci. 1995 Sep 30;768:163-9. doi: 10.1111/j.1749-6632.1995.tb12119.x.

Finasteride for prostatic disease: an updated and comprehensive review.

Expert Opin Drug Metab Toxicol. 2008 Dec;4(12):1561-8. doi: 10.1517/17425250802587058.

引用本文的文献

Optimization of thiazole analogues of resveratrol for induction of NAD(P)H:quinone reductase 1 (QR1).

Bioorg Med Chem. 2012 Dec 15;20(24):7030-9. doi: 10.1016/j.bmc.2012.10.006. Epub 2012 Oct 23.

Identification of key amino acids responsible for the substantially higher affinities of human type 1 3beta-hydroxysteroid dehydrogenase/isomerase (3beta-HSD1) for substrates, coenzymes, and inhibitors relative to human 3beta-HSD2.

J Biol Chem. 2005 Jun 3;280(22):21321-8. doi: 10.1074/jbc.M501269200. Epub 2005 Mar 28.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Finasteride, a selective 5-alpha-reductase inhibitor, in the prevention and treatment of human prostate cancer.

Clin Prostate Cancer. 2004 Mar;2(4):206-8. doi: 10.1016/s1540-0352(11)70045-2.

Finasteride for prevention of prostate cancer.

Med Lett Drugs Ther. 2008 Jun 30;50(1289):49-50.

Guideline supports long-term use of medication to lower prostate cancer risk.

JAMA. 2009 May 6;301(17):1753-4. doi: 10.1001/jama.2009.560.

Prevention of prostate cancer with finasteride.

N Engl J Med. 2003 Oct 16;349(16):1569-72; author reply 1569-72.

Prostate cancer prevention with 5 alpha-reductase inhibitors.

Recent Results Cancer Res. 2011;188:109-14. doi: 10.1007/978-3-642-10858-7_9.

[The Prostate Cancer Prevention Trial (PCPT). Relevance for clinical practice].

Urologe A. 2007 Oct;46(10):1364, 1366-8, 1370. doi: 10.1007/s00120-007-1553-9.

Prostate cancer prevention trials in the USA.

Eur J Cancer. 2000 Jun;36(10):1312-5. doi: 10.1016/s0959-8049(00)00105-2.

High-grade prostate cancer and finasteride.

BJU Int. 2010 Feb;105(4):456-9. doi: 10.1111/j.1464-410X.2009.09089.x. Epub 2009 Nov 20.

The potential application of finasteride for chemoprevention of prostate cancer.

Ann N Y Acad Sci. 1995 Sep 30;768:163-9. doi: 10.1111/j.1749-6632.1995.tb12119.x.

Finasteride for prostatic disease: an updated and comprehensive review.

Expert Opin Drug Metab Toxicol. 2008 Dec;4(12):1561-8. doi: 10.1517/17425250802587058.

引用本文的文献

Optimization of thiazole analogues of resveratrol for induction of NAD(P)H:quinone reductase 1 (QR1).

Bioorg Med Chem. 2012 Dec 15;20(24):7030-9. doi: 10.1016/j.bmc.2012.10.006. Epub 2012 Oct 23.

J Biol Chem. 2005 Jun 3;280(22):21321-8. doi: 10.1074/jbc.M501269200. Epub 2005 Mar 28.